Dual-site targeting of Zika virus NS5 RNA-dependent RNA polymerase reveals novel nucleoside and allosteric inhibitor scaffolds

نویسندگان
doi
10.48309/jmpcr.2026.571942.1981
چکیده

Zika virus (ZIKV) remains a significant global health concern due to its association with severe neurological complications and the lack of approved antiviral therapies. The viral non-structural protein 5 (NS5), particularly its RNA-dependent RNA polymerase (RdRp) domain, is essential for viral replication and immune evasion and lacks a human homolog, making it an attractive antiviral target. Using an integrated structure-guided virtual screening approach, two distinct classes of small-molecule hits were identified, targeting the ZIKV NS5 RdRp. Nucleoside/nucleotide analog-derived compounds (hits 1–5) demonstrated the ability to engage both the catalytic active site and the adjacent allosteric N-pocket simultaneously, resulting in cooperative stabilization of key functional regions of the polymerase. In contrast, non-nucleoside hits (6–10) primarily bound to the allosteric N-pocket, exhibiting classic allosteric inhibition profiles. The identified dual-site nucleoside hits showed improved docking scores, favorable MM-GBSA binding free energies, and stable binding behavior in molecular dynamics simulations compared to their reference scaffolds (sofosbuvir, favipiravir, brincidofovir, galidesivir, and remdesivir). Pharmacokinetic and toxicity predictions further highlighted several lead candidates with balanced developability profiles suitable for further optimization. These findings provide structural insights into dual-site versus allosteric inhibition mechanisms of ZIKV NS5 RdRp and offer promising starting points for the rational design of next-generation flavivirus polymerase inhibitors.